BioCentury
ARTICLE | Company News

Galderma, Nuvo deal

July 30, 2012 7:00 AM UTC

Nuvo will receive $6 million in milestone payments from Galderma under a 2008 deal granting Galderma exclusive, worldwide rights to Pliaglis lidocaine/tetracaine. The milestones were triggered by the...